it means that only 13 percent of the world's population will initially have access to the drugs max lawson the head of oxfam inequality policy division says pharmaceutical companies are putting profits 1st. it's extremely dangerous for the world because rich nations monopolizing the superboy of potential banks and more importantly they're doing deals with big corporation. defending their intellectual property and appropriate meaning that the soup lowing all banks. own. oxfam says there won't be enough vaccine doses to meet global demand the 5 leading vaccine candidates are currently undergoing stage 3 clinical trials however even if all 5 proved to be a success which according to the charity is extremely unlikely around 2 thirds of the world's population will still have to wait until 2022 at least on top of potential drug shortages oxfam says quote the vaccine deals lay bare the inequality between a prosperous and developing countries. now to give you an example the u.k. has managed to secure up to 5 doses per person depending of course on how the trials go now bangladesh for example in st

the trials go while for bangladesh and stark contrast the figure is only one dose per 9 people max lawson again says that prolonged availability of the vaccine in some countries will result in many unnecessary deaths. companies like medan or in the u.s. are only sending their backseat to very rich countries they're sending it or bury high prices somewhere between $16.00 and $35.00 a dollars and you have to have 2 doses so that's like $70.00 per person so they are very clear that they they're doing this to make a profit and they want to make money from this vaccine what we're saying is we need a people's backs and not a profit back saying we need to see. the breaking down of these patent barriers and we need to see open sharing your back same technology to maximise this applause and effective vaccines all over the world as soon as possible the huge economic and human cost of it did learn in the variability of the vaccine if you think of countries like india or south africa of brazil if these countries and north getting access to say from the point to that sink into 2022 then they would hav

it means that only 13 percent of the world's population will initially have access to the drugs max lawson the head of oxfam's inequality policy division says pharmaceutical companies are putting profits 1st. it's extremely dangerous for the world because rich nations monopolizing the super lawyer potential. but more importantly they're doing deals with big corporation which own defending their intellectual property and i prefer meaning that the soup laws. banks being own to. oxfam says there won't be enough vaccine doses to meet global demand the 5 leading vaccine candidates are currently undergoing stage 3 clinical trials however even if all 5 proved to be success which according to the charity is extremely unlikely around 2 thirds of the world's population will still have to wait until 2022 at least on top of potential drug shortages oxfam says quote the vaccine deals lay bare the inequality between a prosperous and a developing countries to give us an example the u.k. has managed to secure up to 5 doses per person depending of course on how the trials go well for bangladesh in stark co

how the trials go well for bangladesh in stark contrast the figure is only one dose but 9 people max lawson again says that prolonged and availability of the vaccine in some countries is going to mean unnecessary deaths companies like their own are in the us are only selling their backs into very rich countries they're selling it at a very high price somewhere between $16.00 and $35.00 a dose and you have to have 2 doses like $70.00 per person so they are buried clear that they are there doing things to make a profit and they want to make money from this vaccine what we're saying is we need a people's backs not a profit need to see. the breaking down of the patent barrier and we need to see open sharing your banks in technology to lose. axa more since applause and effective vaccines all over the world as soon as possible the huge economic and human cost of. a little ability if you go countries like india or south africa of brazil if these countries are not getting access to say. 2022. they would have more luck to their economies would be huge trouble many many people who. do not need to bec

the trials go while for bangladesh the stark contrast the figure is only one dose per 9 people max lawson again says that prolonged an availability of the vaccine in some countries will result in many unnecessary deaths. companies like medan or in the u.s. are only sending their backseat to very rich countries they're setting it at a very high price somewhere between $16.00 and $35.00 a dose and you have to have 2 dices so that's like $70.00 per person so they are very clear that they they're doing this to make a profit and they want to make money from this vaccine what we're saying is we need a people's backs and not a profit back saying we need to see. the breaking down of these patents areas and we need to see open sharing your vaccine technology to maximise the supply safe and effective vaccines all over the world as soon as possible but the huge economic and human cost of it did lie in the variability of the vaccine if you think of countries like india or south africa brazil if these countries and not getting access to safe and effective but staying until 2022 then they would have mo